Phytochemical and pharmacological potential of Medicago sativa: A review

Pharmaceutical Biology

Volumn 49, Issue 2, 2011, Pages 211-220

  Bora, Kundan Singh ^a   Sharma, Anupam ^b  

^a LR Institute of Pharmacy   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

antiatherosclerotic; Antidiabetic; hypocholesterolemic; Medicago sativa; neuroprotective

Indexed keywords

ALANINE; ALKALOID; AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; CANAVANINE; COUMARIN DERIVATIVE; ESCULETIN; FLAVONOID; GEMFIBROZIL; GLUTAMIC ACID; HISTIDINE; LYSINE; MEDICAGO SATIVA EXTRACT; METHIONINE; MYRICETIN; PHENYLALANINE; PHYTOESTROGEN; PHYTOSTEROL; PLANT EXTRACT; QUERCETIN; SAPONIN; SCOPOLETIN; SERINE; TERPENE; THREONINE; TYROSINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN;

ALFALFA; ALLERGY; ARTHRITIS; ASTHMA; ATHEROSCLEROSIS; BLADDER DISEASE; BLOOD CLOTTING DISORDER; BREAST CANCER; CENTRAL NERVOUS SYSTEM DISEASE; COUGHING; DIABETES MELLITUS; DRUG ACTIVITY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; DYSURIA; ENTEROPATHY; ETHNOPHARMACOLOGY; FEVER; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPOPROTEINEMIA TYPE 2; INDIGESTION; INFLAMMATION; INSECT BITE; JAUNDICE; KIDNEY DISEASE; KIDNEY PAIN; MALIGNANT NEOPLASTIC DISEASE; MENOPAUSAL SYNDROME; MYALGIA; NEPHROLITHIASIS; NONHUMAN; PANCYTOPENIA; PHYTOCHEMISTRY; PLANT MORPHOLOGY; PROSTATE DISEASE; REVIEW; RHEUMATOID ARTHRITIS; SCURVY; SKIN DEFECT; STOMACH ULCER; STROKE; SWELLING; SYSTEMATIC REVIEW; THROMBOCYTOPENIC PURPURA; ULCER; URINARY TRACT DISEASE; UTERINE CERVIX CANCER;

ANIMALS; ETHNOPHARMACOLOGY; FEMALE; HUMANS; MEDICAGO SATIVA; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANT EXTRACTS;

FABACEAE; MEDICAGO; MEDICAGO SATIVA;

EID: 79251611882     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.504732     Document Type: Review

References (112)

1. Abdel-Hafez OM. (1993). Constituents of Medicago sativa fruits. Fitoterapia, 64, 381-382.
2. Adler J. (1962). Anti-oestrogenic activity in alfalfa. Vet Record, 74, 1148-1154.
3. Albourine A, Petit-Ramel M, Thomas-David G, Vallon JJ. (1991). Extraction of l-canavanine from soybean (Glycine max) and alfalfa (Medicago sativa). Analysis by high-performance liquid chromatography. J Pharm Belg, 46, 229-235.
4. Aldo T, Luciano P. (1997). Volatiles from Medicago sativa complex flowers. Phytochemistry, 45, 1145-1148.
5. Argentieri MP, DAddabbo T, Tava A, Agostinelli A, Jurzysta M, Avato P. 2008. Evaluation of nematicidal properties of saponins from Medicago spp. Eur J Plant Pathol, 120, 189-197.
6. Avato P, Bucci R, Tava A, Vitali C, Rosato A, Bialy Z, Jurzysta M. (2006). Antimicrobial activity of saponins from Medicago spp. Structureactivity relationship. Phytother Res, 20, 454-457.
7. Barcelo F, Mirales F, Arean CO. (1997). Purification and characterization of ferritin from alfalfa seeds. J Inorg Biochem, 66, 23-27.
8. Barnes DK, Sheaffer CC. (1995). Alfalfa. In: Barnes RF, Miller DA, Nelson CJ, eds. Forages: An Introduction to Grassland. Ames: Iowa State University, pp.205-216.
9. Barnes J, Anderson LA, Philipson JD. (2007). Herbal Medicines, third edition. London: Pharmaceutical Press.
10. Bhavna G, Rashmi SS, Radha G. (2007). Therapeutic uses of Euphorbia thymifolia: A Review. Phcog Rev, 1, 299-304.
11. BHMA (1983). British Herbal Pharmacopoeia (BHP). Cowling (Yorkshire): British Herbal Medical Association.
12. BHMA (1996). British Herbal Pharmacopoeia (BHP). Bournemouth: British Herbal Medical Association.
13. Biagioni M, Alpi A, Picciarelli P. (1990). Aminopeptidases (EC.3.4.11) in alfalfa (Medicago sativa L.) leaves. J Plant Physiol, 135, 559-564.
14. Bialy Z, Jurzysta M, Oleszek W, Piacente S, Pizza C. (1999). Saponins in alfalfa (Medicago sativa L.) root and their structural elucidation. J Agr Food Chem, 47, 3185-3192.
15. Bickhoff EM, Livingston AL, Booth AN. (1960). Estrogenic activity of coumestrol and related compounds. Arch Biochem Biophys, 88, 262-267.
16. Bickhoff EM, Livingston AL, Booth AN. (1964). Tricin from alfalfaisolation and physiologic activity. J Pharm Sci, 53, 1411.
17. Boon H, Smith MJ. (2004). The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, second edition. Toronto (ON): Robert Rose.
18. Boue SM, Wiese TE, Nehls S, Burow ME, Elliott S, Carter-Wientjes CH, Shih BY, McLachlan JA, Cleveland TE. 2003. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J Agr Food Chem, 51, 2193-2199.
19. Brinker F. (2001). Herb Contraindications and Drug Interactions, third edition. Sandy, OR: Eclectic Medical.
20. Cohen BI, Mosbach EH, Matoba N, Suh SO, McSherry CK. (1990). The effect of alfalfa-corn diets on cholesterol metabolism and gallstones in prairie dogs. Lipids, 25, 143-148.
21. DerMarderosian A, Liberti L, Beutler JA, Grauds C, Tatro DS, Cirigliano M, DeSilva D Jr. (2005). Alfalfa. Review of Natural Products: Facts and comparisons. Alphen aan den Rijn, the Netherlands: Wolters Kluwer Health.
22. Dewey D. (2001). Cholestaid. NuPharma, January 1. http://www.drugs.com/ npp/alfalfa.html (accessed 15 January 2010).
23. Dixit VP, Joshi SC. (1985). Antiatherosclerotic effects of alfalfa meal ingestion in chicks: A biochemical evaluation. Indian J Physiol Pharmacol, 29, 47-50.
24. Dixon RA, Steele CL. (1999). Flavonoids and isoflavonoids - A gold mine for metabolic engineering. Trends Plant Sci, 4, 394-400.
25. Doehlert DC, Duke SH, Anderson L. (1982). Amylases from alfalfa (Medicago sativa L.) roots. Plant Physiol, 69, 1096-1102.
26. Duke J. (1985). Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press.
27. Duke J. (2002). American Agricultural Research Service-Phytochemical & Ethnobotanical Database. Available at: http://www.ars-grin.gov/duke/index. html (accessed 10 August 2009).
28. Dutu LE, Istudor V, Loloiu T, Radulescu V. (2002). Research on polyphenolic compounds from Medicago sativa L. Farmacia (Bucharest Romania), 50, 44-56.
29. Ehsanpour AA, Razavizadeh R. (2005). Effect of UV-C on drought tolerance of alfalfa (Medicago sativa) callus. Am J Biochem Biotechnol, 1, 107-110.
30. El-Khrisy EAM, Abdel Hafez OM, Khattab AA, Ahmed KM. (1994). Chemical constituents of Medicago sativa L. Bull Nat Res Cent (Egypt), 19, 117-122.
31. FAO. (2006). FAOSTAT-Food and Agriculture Organization of the United Nations. Available at http://faostat.fao.org (accessed 05 March 2010).
32. Farnsworth NR. (1995). Alfalfa pills and autoimmune diseases. Am J Clin Nutr, 62, 1026-1028.
33. Finkler K. (1985). Spiritualist Healers in Mexico. South Hadley, MA: Bergin & Garvey.
34. Francoise F, Daniel Le R, John GS. (1991). Effects of salt stress on amino acid organic acid and carbohydrate composition of roots bacteroids and cytosol of Alfalfa (Medicago sativa L.). Plant Physiol, 96, 1228-1236.
35. Fushiya S, Tamura T, Tashiro T, Nozoe S. (1984). Structure and synthesis of medicanine, a new amino acid from Medicago sativa. Heterocycles, 22, 1039-1040.
36. Garrett BJ, Cheeke PR, Miranda CL, Goeger DE, Buhler DR. (1982). Consumption of poisonous plants (Senecio jacobaea, Symphytum officinale, Pteridium aquilinum, Hypericum perforatum) by rats chronic toxicity mineral metabolism and hepatic drugmetabolizing enzymes. Toxicol Lett, 10, 183-188.
37. Gray AM, Flatt PR. (1997a). Pancreatic and extra-pancreatic effects of the traditional anti-diabetic plant Medicago sativa (Lucerne). Brit J Nutr, 78, 325-334.
38. Gray AM, Flatt PR. (1997b). Natures own pharmacy the diabetes perspective. P Nutr Soc, 56, 507-5 I7.
39. Gupta BK, Nandra KS, Chopra AK. (1981). Chemical and mineral composition on different cuttings of lucerne (Medicago sativa). J Res (Punjab Agricultural University), 18, 345-348.
40. Gwon CH, Kim JD. (2006). Plant ground powder or extract of M. sativa L. Avena sativa L. or Cirsium japonicum having growth inhibition effect of Echinochloa crusgalli Wight. Korean Republic Kongkae: Taeho Kongbo.
41. Hall D. (1981). The Herb Tea Book. Connecticut: Keats Publishing, 234-239.
42. Hendler SS. (1995). The Doctors Vitamin & Mineral Encyclopedia. London: Leopard.
43. Heywood VH, Ball PW. (1968). Leguminosae. In: Tutin TG, Heywood VH, Burges NA, Moore DM, Valentine DH, Walters SM, Webb DA, Eds. Flora Europaea, Vol II. Cambridge: Cambridge University Press, pp. 245-260.
44. Horst RL, Reinhardt TA, Russell JR, Napoli JL. (1984). The isolation and identification of vitamin D2 and vitamin D3 from Medicago sativa (alfalfa plant). Arch Biochem Biophys, 231, 67-71.
45. Huhman DV, Sumner LW. (2002). Metabolic profiling of saponins in Medicago sativa and Medicago truncatula using HPLC coupled to an electrospray ion-trap mass spectrometer. Phytochemistry, 59, 347-360.
46. Huyghe C, Bertin E, Landry N. (2007). Medicinal and Nutraceutical Uses of Alfalfa (Medicago sativa L.). A review. In: Acharya SN, Thomas JE, eds. Advances in Medicinal Plant Research. Trivandrum, Kerala, India: Research Signpost, pp. 147-172.
47. Inamul H. (2004). Safety of medicinal plants. Pakistan J Med Res, 43, 1-8.
48. Jorge AV, Antonio I, Luis L, Donato AS. (1985). Effects of l-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum, 28, 52-57.
49. Khaleel AEG, Mohamed Z, El-Maraghy SA, Hifnawy MS, Abdel-Sattar E. (2005). Study of hypocholesterolemic and antiatherosclerotic properties of Medicago sativa L. cultivated in Egypt. Yaowu Shipin Fenxi, 13, 212-218.
50. Kitagawa I, Taniyama T, Murakami T, Yoshihara M, Yoshikawa M. (1988). Saponin and sapogenol. XLVI. On the constituents in aerial part of American alfalfa Medicago sativa L. The structure of dehydrosoyasaponin I. Yakugaku Zasshi, 108, 547-554.
51. Kowalska I, Stochmal A, Kapusta I, Janda B, Pizza C, Piacente S, Oleszek W. (2007). Flavonoids from Barrel Medic (Medicago truncatula) aerial parts. J Agr Food Chem, 55, 2645-2652.
52. Kundan SB, Anupam S. (2010). Evaluation of antioxidant and cerebroprotective effect of Medicago sativa Linn. against ischemia and reperfusion insult. eCAM, 1-9. Available at: .oxfordjournals.org (accessed 16 April 2010).
53. Levy S. (1999). New product newswire. Drug Top, 19, 22-26.
54. Lihu M, Pedak E. (1979). Chemical composition of alfalfa (Medicago sativa L.) in different stages of growth. Teaduslike Toode Kogumik, 49, 104-109.
55. Li-Shar H, Claus G. (1988). Sterol and phospholipid changes during alfalfa seed germination. Phytochemistry, 27, 2049-2053.
56. Lust J. (1974). The Herb Book. New York: Benedict Lust Publications
57. Malinow MR, Bardana EJJ, Goodnight SHJ. (1981a). Pancytopenia during ingestion of alfalfa seeds. Lancet, 1, 615.
58. Malinow MR, Bardana EJJ, Pirofsky B, Craig S, McLaughlin P. (1982b). Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts role of a nonprotein amino acid. Science, 216, 415-417.
59. Malinow MR, Connor WE, McLaughlin P, Stafford C, Lin DS, Livingston AL, Kohler GO, McNulty WP. (1981b). Cholesterol and bile acid balance in Macaca fascicularis. Effects of alfalfa saponins. J Clin Invest, 67, 156-162.
60. Malinow MR, McLaughlin P, Papworth L, Stafford C, Kohler GO, Livingston AL, Cheeke PR. (1977a). Effect of alfalfa saponins on intestinal cholesterol absorption in rats. Am J Clin Nutr, 30, 2061-2067.
61. Malinow MR, McLaughlin KGO, Livingston AL. (1977b). Prevention of elevated cholesterolemia in monkeys by alfalfa saponins. Steroids, 29, 105-110.
62. Malinow MR, McNulty WP, Houghton DC, Kessler S, Stenzel P, Goodnight SHJ, Bardana EJJ, Palotay JL, McLaughlin P, Livingston AL. (1982a). Lack of toxicity of alfalfa saponins in Cynomolgus macaques. J Medical Primatol, 11, 106-118.
63. Malinow MR, McNulty WP, McLaughlin P, Stafford C, Burns AK, Livingston AL, Kohler GO. (1981c). The toxicity of alfalfa saponins in rats. Food Cosmet Toxicol, 19, 443-445.
64. Massiot G, Catherine L, Dominique G, Louisette Le MO. (1988). Reinvestigation of the sapogenins and prosapogenins from alfalfa (Medicago sativa). J Agr Food Chem, 36, 902.
65. Massiot G, Lavaud C, Besson V, Le Men-Olivier L, Van Binst G. (1991). Saponins from aerial parts of alfalfa (Medicago sativa). J Agr Food Chem, 39, 78-82.
66. Mego V, Erdelsky K. (1977). Free amino acids in alfalfa (Medicago sativa) L. Physiol Plantarum, 13, 49-55.
67. Meyer JH. (1954). The utilization of alfalfa and alfalfa fiber fractions by growing rats. J Nutr, 237-247.
68. Michael A, Francine G, Matthias H. (2007). Plants traditionally used in age related brain disorders-A survey of ethnobotanical literature. J Ethnopharmacol, 113, 363-381.
69. Mills S. (1985). The Dictionary of Modern Herbalsim. Wellingborough: Thorsons.
70. Mills S. (1994). The Complete Guide to Modern Herbalism. Wellingborough: Thorsons.
71. Minerva G. (1998). Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent. Universita degli Studi- Siena, 50, 207-211.
72. Mohamed B, Abderrahim Z, Hassane M, Abdelhafid T, Abdelkhaleq L. (2006). Medicinal plants with potential antidiabetic activity A review of ten years of herbal medicine research (1990-2000). Int J Diab Metab, 14, 1-25.
73. Molgaard J, von Schenck H, Olsson AG. (1987). Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemia. Atherosclerosis, 65, 173-179.
74. Natelson S. (1985). Canavanine in alfalfa (Medicago sativa). Experientia, 41, 257-259.
75. Natelson S. (1985). Canavanine to arginine ratio in alfalfa (Medicago sativa) clover (Trifolium) and the jack bean (Canavalia ensiformis). J Agr Food Chem, 33, 413-419.
76. Newby VK, Sablon RM, Synge RLM, Vande CK, Van S, Christiaan F. (1980). Free and bound phenolic acids of lucerne (Medicago sativa cv Europe). Phytochemistry, 19, 651-657.
77. Oleszek W. (1988). Solid-phase extraction-fractionation of alfalfa saponins. J Sci Food Agr, 44, 43-49.
78. Oleszek W, Jurzysta M. (1986). Isolation chemical characterization and biological activity of alfalfa (Medicago media Pers.) root saponins. Acta Soc Bot Pol, 55, 23-33.
79. Oleszek W, Jurzysta M, Ploszynski M, Colquhoun IJ, Price KR, Fenwick GR. (1992). Zahnic acid tridesmoside and other dominant saponins from alfalfa (Medicago sativa L.) aerial parts. J Agr Food Chem, 40, 191-196.
80. Orr JD, Sumner LW, Edwards R, Dixon RA. (1993). Determination of cinnamic acid and 4-coumaric acid in alfalfa (Medicago sativa L.) cell suspension cultures by gas chromatography. Phytochem Anal, 4, 124-130.
81. Parry AD, Edwards R. (1994). Characterization of flavonoid O-glycosyltransferases from alfalfa (Medicago sativa). Acta Horticulturae, 381, 154-157.
82. Piretti MV, Zeli F, Pistore R. (1982). Flavonoid polyphenols in alfalfa (Medicago sativa). Gazz Chim Ital, 112, 47-50.
83. Potgieter SJ. (2005). Nutritional supplement extracted from alfalfa (Medicago sativa). PCT Int. Appl. WIPO Patent Application WO/2005/002357 (South Africa) Available at http://www.wipo.int/pctdb/en/wo.jsp?wo=2005002357 (accessed 02 March 2010).
84. Reilly P. (1989). Clinical application-Medicago sativa extracts. J Naturopathic Med, 1, 455-460.
85. Roberts JL, Hayashi JA. (1983). Exacerbation of SLE associated with alfalfa ingestion. New Engl J Med, 308, 1361.
86. Rodriguez-Garay B, Phillips GC, Kuehn GD. (1989). Detection of norspermidine and norspermine in Medicago sativa L. (alfalfa). Plant Physiol, 89, 525-529.
87. Rubenstein AH, Levin NW, Elliott GA. (1962). Manganese-induced hypoglycemia. Lancet, 2, 1348-1351.
88. Shao H, Dixon RA, Wang X. (2007). Crystal structure of vestitone reductase from alfalfa (Medicago sativa L). J Mol Biol, 369, 265-276.
89. Song Y, Wei J. (2007). Health beverage containing Medicago sativa. Faming Zhuanli Shenqing Gongkai Shuomingshu, 7
90. Sroka Z, Jurzysta M, Tylcz J, Rzadkowska-Bodalska H. (1997). Stimulation of pancreatic lipase activity by saponins isolated from Medicago sativa. Z Naturforsch C, 52, 235-239.
91. Steppler HA. (1987). ICRAF and a decade of agroforestry development. In: Steppler HA, Nair PKR, eds. Agroforestry: A Decade of Development. Nairobi, Kenya: International Council for Research in Agroforestry, pp. 13-24.
92. Stochmal A, Simonet AM, Macias FA, Oliveira MA, Abreu JM, Nash R, Oleszek W. 2001. Acylated apigenin glycosides from alfalfa (Medicago sativa L. var. Artal). Phytochemistry, 57, 1223-1226.
93. Stochmal A, Oleszek W. (2007). Seasonal and structural changes of flavones in alfalfa (Medicago sativa) aerial parts. J Food Agr Env, 5, 170-174.
94. Story JA, LePage SL, Petro MS, West LG, Cassidy MM, Lightfoot FG, Vahouny GV. (1984). Interactions of alfalfa plant and sprout saponins with cholesterol in vitro and in cholesterol-fed rats. Am J Clin Nutr, 39, 917-929.
95. Sumner LW, Paiva NL, Dixon RA, Geno PW. (1996). High performance liquid chromatography/continuous-flow liquid secondary ion mass spectrometry of flavonoid glycosides in leguminous plant extracts. J Mass Spectrom, 31, 472-485.
96. Swanston SK, Day C, Bailey CJ, Flatt PR. (1990). Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia, 33, 462-464.
97. Tamsyn SA, Thring PH, Declan PN. (2009). Anti-collagenase antielastase and anti-oxidant activities of extracts from 21 plants. BMC Complement Altern Med, 9, 27-37.
98. Teuber LR, Brick MA. (1988). Morphology and anatomy. In: Hanson AA, Barnes DK, Hill Jr RR, eds. Alfalfa and Alfalfa Improvement. Madison, WI, 125-162.
99. Timbekova AE. (1995). Chemistry and Biological Activity of Glycosides from Medicago sativa. Book of Abstracts of the 210th ACS National Meeting, Chicago, IL, August 20-24. Washington, DC: American Chemical Society.
100. Timbekova AE, Isaev MI, Abubakirov NK. (1996). Chemistry and biological activity of triterpenoid glycosides from Medicago sativa. Adv Exp Med Biol, 405, 171-182.
101. Toth EC, Vissi E, Kovacs I, Szoke A, Arino J, Gergely P, Dudits D, Dombradi V. (2000). Protein phosphatase 2A holoenzyme and its subunits from Medicago sativa. Plant Mol Biol, 43, 527-536.
102. Volynets AP, Dubikovskii GP, Bardinov FG, Palchenko LA, Tikhon ZK. (1979). Study of the phenol compounds of alfalfa Medicago sativa. Seryya Biyalagichnykh Navuk, 4, 40-44.
103. White RD, Krumperman PH, Cheeke PR, Buhler DR. (1983). An evaluation of acetone extracts from six plants in the Ames mutagenicity test. Toxicol Lett, 15, 25-31.
104. Wieslaw O, Keith RP, Ian JC, Marian J, Michal P, Roger, GF. (1990). Isolation and identification of alfalfa (Medicago sativa L.) root saponins their activity in relation to a fungal bioassay. J Agr Food Chem, 38, 1810-1817.
105. Wilcox EB, Galloway LS. (1961). Serum and liver cholesterol total lipids and lipid phosphorus levels of rats under various dietary regimes. Am J Clin Nutr, 9, 236-243.
106. Worthington RB, Breskin MF. (1983). A pharmacists guide to controversial nutrition products Am Pharm, 23, 30-42.
107. Xiaoqiang W, Xianzhi H, Jianqiao L, Hui S, Zhenzhan C, Richard AD. (2006). Crystal structure of isoflavone reductase from alfalfa (Medicago sativa L.). J Mol Biol, 358 1341-1352.
108. Xiong S. (2003). Medicinal-use extract of Medicago sativa root. Faming Zhuanli Shenqing Gongkai Shuomingshu, 6.
109. Yanar M, Ercen Z, Hunt AO, Buyukcapar HM. (2008). The use of alfalfa (Medicago sativa) as a natural carotenoid source in diets of goldfish Carassius auratus. Aquaculture, 284, 196-200.
110. Yu C, Guo J, Shen H, Liang D, Zhao N, Wen J. (2007). Method for preparing saponin extract of Medicago sativa and its application in manufacturing hypolipidemic agents and antiatherosclerotics. Faming Zhuanli Shenqing Gongkai Shuomingshu, 10.
111. Zhang L, Zhang D, Feng K. (2006). Inhibition of refined components of Medicago sativa polysaccharides to the activities of reverse transcriptase of HIV and protease of HIV. Zhongguo Shipin Xuebao, 6, 59-62.
112. Zhao WS, Zhang YQ, Ren LJ, Zhang L, Yang J. (1993). Immunopotentiating effects of polysaccharides isolated from Medicago sativa L. Zhongguo Yao Li Xue Bao, 14, 273-276.